Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD5 (clone CRIS1G). We employs the AAV (EF1α-mCherry-TFIIA-NotI) vector components and the SynExpress system of the Single base pair Prime Editing/Adaptive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD5
Clone
CRIS1G
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
mCherry
Promoter
EF1α
Effector Gene
TFIIA
Insertion Sites
NotI
Gene Modification
Prime Editing
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.9
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.